Professional Documents
Culture Documents
INTERNAL GUIDE
EXTERNAL GUIDE
Mr. N C BHANDARI
Sr. Manager-FINANCE
Shilpa Medicare Limited
CERTIFICATE
This is to certify
that
Mrs.
SOGRA
NAVEED
JUHI
bearing
PRINCIPAL S.L.N.COLLEGE OF
ENGINEERING
CERTIFICATE
This is to certify
that
Mrs.
SOGRA
NAVEED
JUHI
bearing
CERTIFICATE
This is to certify
that
Mrs.
SOGRA
NAVEED
JUHI
bearing
Internal Guide
Date: 13/02/2015
DECLARATION
Place:
Signature
Date:
(USN: 3SL13MBA28)
ACKNOWLEDGEMENT
It is my privilege to express a few words of gratitude and respect through this project
report to all those who guided and inspired me in completing this project.
I express my deep gratitude to Visvesvaraya University, Belgaum, which gave me an
opportunity to undertake this project by including the summer project in its program of Master
of Business Administration.
I owe my utmost gratitude to Shri. C.H Biradar (Principal), Amaresh Patil (Head of
the Dept.), my Internal Guide Prof. Bhgayalaxmi Rastapur and the faculty SLN college of
Engineering, Raichur, for their valuable guidance and useful suggestions.
I owe my sincere gratitude to Mr. Amrut Lahoti (Senior Manager), my External Guide
Mr. N C Bandhari, who always stood up to guide me and to resolve all my queries amidst their
busy schedule, and all the staff of Shilpa Medicare Limited, Raichur, who nurtured my
dedication towards the work and continuous practice in the course of project.
My deep sense of gratitude and respect to my parents for their support and
encouragement. Finally, I wish to sincerely acknowledge my gratitude to all the persons who
have helped me directly or indirectly in completing this project successfully.
Place:
Signature
Date:
(USN: 3SL13MBA28)
TABLE OF CONTENTS
CHAPTER
CONTENTS
Page number
EXECUTIVE SUMMARY
11
INTRODUCTION
Introduction about the Internship
Topic chosen for study
Need for the study
Objectives of the study
Scope of the study
Methodology adopted
Literature review and
Limitations of the study
12 -21
13
14
14
15
15
15
16-21
21
22-38
24
25
25-26
27-28
29
29
30
31-33
34-38
39-48
49-57
58-59
BIBLIOGRAPHY
60
ANNEXURE
61-63
LIST OF TABLES
Table
Number.
Table -1
ONCOLOGY APIS
26
Table -2
26
Table -3
NON-ONCOLOGY APIS
Particulars
Page
Numbers.
26
NON-ONCOLOGY APIS UNDER DEVELOPMENT
Table -4
Ownership Pattern
28
Table -5
SWOT ANALYSIS
30
Table -6
Profit and Loss Account for the Year Ended 31st March
2014
35
Table -7
35-36
Table -8
RATIO ANALYSIS
37-38
Table -9
49
Table -9.1
50
Table -10
51
Table -11
52
Table -12
53
Table -13
54
Table -14
55
Table -15
56
Table -16
57
Graph
Number.
Particulars
Page
Numbers
Chart-1
28
Graph-1
49
Graph-1.1
50
Graph-2
51
Graph-3
52
Graph-4
53
Graph-5
54
Graph-6
55
Graph-7
56
Graph-8
57
10
EXECUTIVE SUMMARY
Established in 1987, Shilpa Medicare Limited has carved a niche for itself in the
exceedingly competitive and quality-conscious sphere of pharmaceutical manufacturing. It
produce and export consistently high-quality active pharmaceutical ingredients fine
chemicals, intermediates, herbal products and specialty chemical products using
sophisticated technology,
The
company has earned its spurs as a successful and reliable partner within the pharmaceutical
industry. Buyers within the country and from across the borders count on its fast track
integrated process development and finely honed expertise of its skilled and experienced
personnel.
The purpose of this study is to understand the management of working capital in
Shilpa Medicare Ltd., and to learn the concept of business decision-making. The goal of
working capital management is to ensure that the firm is able to continue its operation and
that it has sufficient cash flow to satisfy both maturing short term debt and upcoming
operational expenses. Working capital is used in Shilpa Medicare Ltd., for the following
purpose:-Raw material, work in progress, finished goods, inventories, sundry debtors, and
day today cash requirements. The Shilpa Medicare Ltd., keep certain funds which is
automatically available to finance the current assets requirements. The various information
regarding Working Capital Management such as classification, determinants, sources
have been discussed , Ratio Analysis has been Carried out using Financial Information for
last five accounting years i.e. from 2010 to 2014 Ratios like Working capital Turnover
Ratio, Quick Ratio, Current Ratio, Inventory Turnover Ratio, Debtor Turnover Ratio,
Creditors turnover ratio have also been analyzed. A Statement of Changes in Working
Capital has also been analyzed. Main SWOT of the organization is postive, the Company
produces and exports consistently high-quality Pharmaceutical Products. Plant running
from past 21 yrs., there is no major break down because of close supervision and
maintenance. Various measures are taken to prevent the environmental hazard by the
organization to maintain ecological balance. Shilpa Medicare Ltd., is having a better
opportunity to setup a new plant in abroad since the export market for Shilpa Medicare
Ltd., products is very well established.
At Shilpa Medicare, the working capital management has shown increase in the
period of study. This shows working capital is managed effectively and all the other
departments are working in perfect co-ordination to ensure the progress of Shilpa Medicare,
but I have given some Suggestions & Conclusions on the basis of my Project study.
H.K.E. SOCIETYS
11
11
CHAPTER 1
INTRODUCTION
An organization in order to attain the objective has to satisfy itself before satisfying
the customers. The organization generally comes into existence with the idea of attaining
their objectives through manufacturing products or rending service, to produce a very high
quality products or service it require factors of production viz, land, labour, capital and
enterprise or organization. Of the four factors enterprise is the most important because it is
due to the enterprise or on organization the most appropriate blending of factors of
production take place, without it the other three have no significance as they complete
depend upon organization.
H.K.E. SOCIETYS
12
12
The organization culture is very good and it does create a homely atmosphere and
it motivates to learn. I learned how to apply theory into practical application. In corporate
world it is necessary to be patient and polite, this company has made me to incorporate this
important qualities in my life.
During the first week, it was totally a new experience entering into the organization.
On the first day of the training, factory manager detailed us very clearly about the company
& guidelines to be followed with respect to maintaining the discipline of the organization
and also informed the safety measures.
During the twelve weeks of the project in Shilpa Medicare Ltd I learnt about the
various departments of the company and the way they function, way to deal and interact
with the clients and amongst the employees, gained practical knowledge about financial
transactions, learnt the importance of team spirit and unity at work to be successful.
Finally I would like to mention the name of Mr. N C Bhandari, who guided me
through everything I did during the project. Totally it was a highly useful training for me
in the company. This has added value in my academic learning.
H.K.E. SOCIETYS
13
13
As from the above discussion it is clear that the working capital is very important
part of a business. In other words we can say that the working capital is the heartbeat of the
company. As the fastness and slowness of the heartbeat, are not the indicators of the good
health. Same in case of working capital, the excess and shortage of working capital also
not good for a companys liquidity.
Hence, because of all of the above reasons one should know how to manage the
working capital of the company, so the present study is conducted in Shilpa Medicare Ltd,
for the purpose of knowing the management of working capital.
H.K.E. SOCIETYS
14
14
METHODOLOGY ADOPTED
Data Collection
Sources of Data
I have collected my information from the following sources, which helped me to make this
report. The sources have divided into two parts such as:
Primary Data:
Primary data are the data collected directly by the officer of finance department because
they are not previously collected. Primary data is collected by interview certain managers
who were chosen on the basis of their in depth knowledge & work experience at Shilpa
Medicare Limited.
Secondary Data:
Secondary data are those data, which are previously collected and compiled for other
purpose or further investigation. In this report the secondary data was collected by referring
to:
Annual reports
Balance sheet
Websites
H.K.E. SOCIETYS
15
15
LITERATURE REVIEW
AN OVER VIEW
It gives an overview of what has been said, who the key writers are, what
are the prevailing theories and hypotheses, what questions are being asked, and
what methods and methodologies are appropriate and useful. As such, it is not
in itself primary research, but rather it reports on other findings. Literature
reviews can give you an overview or act as a stepping stone. It also provide a
solid background for a research paper's investigation.
H.K.E. SOCIETYS
16
16
Main part
Conclusions
A literature review is a piece of discursive prose, not a list describing or
summarizing one piece of literature after another.
It's usually a bad sign to see every paragraph beginning with the name of a
researcher. Instead, organize the literature review into sections that present
themes or identify trends, including relevant theory.
17
17
H.K.E. SOCIETYS
18
18
MANY RESEARCHERS
DIFFERENT
VIEWS
HAVE STUDIED
AND
IN
WORKING
DIFFERENT
CAPITAL
ENVIRONMENTS.
FROM
THE
RELATED LITERATURE
The importance of working capital management is not new to the finance literature.
Over twenty years ago, Largay and Stickney (1980) reported that the then-recent
bankruptcy of W.T. Grant, a nationwide chain of department stores, should have been
anticipated because the corporation had been running a deficit cash flow from operations
for eight of the last ten years of its corporate life. As part of a study of the Fortune 500s
financial management practices. Following are the important views of scholars about
working capital management.
H.K.E. SOCIETYS
19
19
The study found that the cash conversion cycle was of more importance as a measure of
liquidity than the current ratio that affects profitability. The size variable was found to have
significant effect on profitability at the industry level. The results were stable and had
important implications for liquidity management in various Saudi companies. First, it was
H.K.E. SOCIETYS
20
20
clear that there was a negative relationship between profitability and liquidity indicators
such as current ratio and cash gap in the Saudi sample examined. Second, the study also
revealed that there was great variation among industries with respect to the significant
measure of liquidity.
D. BERGAMI ROBERT (2007) :
Analysis that that international trade transactions carry inherently more risk than
domestic trade transactions, because of differences in culture, business processes, laws and
regulations. It is therefore important for traders to ensure that payment is received for goods
dispatched and that the goods received and paid for comply with the contract of sale. One
effective way of managing these risks has been for traders to rely on the letter of credit as
a payment method. However for exporters in particular, the letter of credit has presented
difficulties in meeting the compliance requirements necessary for the payment to be
triggered.
The current rules that govern letter of credit transactions(UCP 500) have been under
review for the past three years and an updated set of rules (UCP 600) is expected to be
introduced on 1July 2007. This paper focuses on the changes mooted for 2007and compares
these main issues with the existing rules and other associated guidelines and regulations
governing this method of payment. This paper considers the implication to changes of letter
of credit transactions and the sharing of risk. Firstly the paper provides some background
to letters of credit, then comments on existing literature and models, and subsequently an
analysis of the most important changes to the existing rules, before reaching a conclusion.
The conclusion is that the UCP 600 have not paid enough consideration to traders and
service providers and are likely to engender an environment of uncertainty for exporters in
particular.
H.K.E. SOCIETYS
21
21
CHAPTER 2
INDUSTRY PROFILE
Global Indusry Overview:
The global pharmaceutical industry is expected to be worth more than
$ 1 trillion in 2014, growing at the compound annual growth rate of 4-5% over the five year
period.
The global pharmaceutical industry is a multinational industry that is a
highly regulated, capital intensive, and which is driven by large research and development
expenditures. The industry is primarily privately owned and is technologically sophisticated.
The strong growth in the developed and emerging countries will help to boost sales over the
next five years.
Emerging markets such as China, South Korea, Brazil, Russia and
Turkey have been experienced double-digit growth signaling an important shift occurring
in the pharmaceutical industry. As growth in the mature markets is coming to flat, industry
attention is shifting to smaller, developing markets that are doing exceptionally well.
H.K.E. SOCIETYS
22
22
Currently, Indian drugs are exported to more than 200 countries in the world, with
the US as the key market. It is responsible for about 40 per cent of the generic and over-thecounter drugs consumed in the US. During the year 2013, Foreign Direct Investment (FDI)
into the Indian pharmaceutical sector has more than doubled.
Substantial increase of expenditure by the Government of India and its states would
definitely create further demand to the pharmaceuticals. With 70 per cent of Indias
population residing in rural areas, pharma companies have immense opportunities to tap this
market. Demand for generic medicines in these regions has seen a sharp growth, and various
companies are investing in the distribution network in rural areas. The share of generic drugs
is expected to continue increasing. Oncology will be a key area of growth in Indias
healthcare sector. With increase in emphasis on health coverage both by central and state
governments, spending on coverage of medicines for oncology will see substantial rise
in next 3-5 years.
COMPANY PROFILE
Background and Inception of the Company
Established in 1987, Shilpa Medicare Limited has carved a niche for itself in the
exceedingly competitive and quality-conscious sphere of pharmaceutical manufacturing. It
produce and export consistently high-quality active pharmaceutical ingredients fine
chemicals, intermediates, herbal products and specialty chemical products using
sophisticated technology,
The
company has earned its spurs as a successful and reliable partner within the pharmaceutical
industry. Buyers within the country and from across the borders count on its fast track
integrated process development and finely honed expertise of its skilled and experienced
personnel. The Company is already exporting to USA, Canada, Australia, Japan and
European Countries viz., Germany, Switzerland, Netherlands, Belgium, Spain, Greece,
Cyprus, Italy, United Kingdom etc., South American Countries like Mexico, Brazil,
Columbia etc., African Countries like Kenya, Nigeria and West Indies etc., Asian Countries
like Singapore, Taiwan, China, Malaysia, Thailand and closer to home to Iran, Egypt,
Pakistan and Bangladesh. Shilpa Medicare is synergizing strength through tie-ups for
manufacturing products and co-marketing rights, for it believes in working together and
sharing success. Being proactive in approach, the company continually seeks out enquiry's
for development of new products drawing from the extensive knowledge-base of its
qualified and experienced people as well as sophisticated facilities.
H.K.E. SOCIETYS
23
23
Incorporation Date
Area
Company Head Office
Fax
Phone
E-mail
Web
PROMOTERS
Board of Directors
Shri Omprakash Inani
Chairman
ShriVishnukant C Bhutada
Managing Director
Independent Director
Independent Director
Independent Director
Independent Director
Independent Director
Independent Director
Board Committees :
Audit Committee
Venugopal Loya - Chairman
Omprakash Inani - Member
Pramod Kasat - Member
Rajender Sunki Reddy Member
H.K.E. SOCIETYS
Auditors
Bohara Bhandari Bung And Associates
Chartered Accountants
Amar Complex, M.G. Road
Raichur 584 101
24
24
QUALITY POLICY
Shilpa Medicare provides consistent quality to the customers. Strict quality assurance is
inherent in every step of our process, from incoming raw materials, maintenance, and
manufacture to finally shipment of the finished product. Our manufacturing facilities and
procedures are standardized to provide the international quality attributes to the products
consistently for each batch through a well-documented, validated and audited system. The
quality assurance of our products is our responsibility and all the departments of the
company share this responsibility by following all the requisite measures and resources to
achieve these goals.
We follow strict quality standards to ensure that all the products being manufactured are
consistently safe, effective and bear good quality. We ensure that all our products comply
with required quality parameters, and consistently meet their specifications. We adhere to
the responsible care programme to ensure optimum customer satisfaction. Adherence to
cGMP norms is an integral part of our total quality management system. We shall always
strive to maintain our reputation for consistent quality, service and timely delivery.
high-quality
Active
Pharmaceutical
Ingredients
Fine
Chemicals,
H.K.E. SOCIETYS
25
25
TABLE 1
TABLE 2
UNDER DEVELOPMENT-ONCOLOGY APIS
PRODUCTS UNDER DEVELOPMENT (Oncology)
Abiraterone Acetate
Bosutinib
Enzalutamide
Exemestane
LapatinibDitosylate
Procarbazine
Regorafenib
Axitinib
Crizotinib
Estramustine
Gefitinib
Nilotinib
Pralatrexate
Temsirolimus
TABLE 3
NON-ONCOLOGY APIS
Acebrophylline
AmbroxolHCl
Echothiophate
Fingolimod HCl
Nifedipine
Perfenidone
H.K.E. SOCIETYS
PrucaloprideSuccinate
Rivastigmine
Sildenafil Citrate
Ursodeoxycholic acid
Valsartan
Odanacatib
Tofacitinib
26
26
AREA OF OPERATION
Shilpa Medicare Ltd has global presence in its operations, the plants and offices of the
company have been established in the following countries.
Italy
Germany
China
Japan
Australia
USA
Turkey
Regulatory Approvals
Regulatory Authorities
Raichur
Unit I
Raichur
Unit II
WHO-GMP
KFDA - Korea
DSIR, Govt. of India
PMDA-Japan
TGA-Australia
BSG-Hamburg
Afssaps-France
Infarmed-Portugal
TPD-Canada
EDQM (CEP)
USFDA (Inspected)
UNITS
I.
II.
III.
IV.
Raichur Unit
Jadcherla Unit
Hyderabad unit-Nu Therapeutics
Shadnagar Unit
H.K.E. SOCIETYS
27
27
Ownership Pattern
TABLE 4
HOLDER'S NAME
Promoter and Promoter Group
Banks Mutual Funds
Financial Institutions
Foreign Institutions Investors
Bodies Corporate
Individual shareholders holding
nominal sharecapital up to Rs.l lakh.
Individual shareholders holding
nominal share capital in excess of
Rs.l lakh
Directors
Trusts
F. C. B
Non-resident Indians
HUF
Clearing Members
5.13%
59250
1250
3000000
926661
209819
42706
0.15%
0.00%
7.78%
2.45%
0.54%
0.11%
Pie Diagram 1
Chart Title
8%
0%
%
5%
Foreign Institutions
Investors
10%
%
2%
Bodies Corporate
10%
53%
6%
15%
%
0%
0
Individual shareholders
holding nominal sharecapital
up to Rs.l lakh.
Individual shareholders
holding nominal share
capital in excess of Rs.l lakh
Directors
Trusts
F. C. B
H.K.E. SOCIETYS
28
28
INFRASTRUCTURAL FACILITIES
The Company has state of the art facilities for the employees. It gives importance to the
environment and takes the utmost care of health of the workers. The company is situated
in the outskirts of the city and is away from the pollution causing due to vehicles. The
company has 20 acres. The space is also used for greenery concentrating on the
environment that creates a good working condition for the employees. The company
provides all the facilities to the employees, like:
Canteen Facility
Quality assurance
Planning
Wash rooms
Drinking water
Transport facility
First Aid
COMPETITORS INFORMATION
Cipla
Piramal Healthcare
Ranbaxy Labs
Dr Reddys Lab
Sun Pharma
H.K.E. SOCIETYS
29
29
SWOT ANALYSIS
SWOT-Acronym for Strengths, Weaknesses, Opportunities, and Threats. It is a
Technique that is credited to Albert Humphrey who led a research project at Stanford
University in the 1960s and 1970s. It is a structured planning method used to evaluate the
strengths, weaknesses, opportunities and threats involved in a project or in a business
venture.
This section of the Report will focus on the SWOT Analysis of Shilpa Medicare
Ltd., and the below highlighted is the SWOT framework summary.
TABLE 5
STRENGTHS
WEAKNESS
Cost competitiveness due to lower
Company not getting quality man
labour cost and production cost
Strong marketing and distribution
network in domestic as well as
international market
Superior management Talent.
Committed employees.
Benefits provided by government
to 100% EOU Unit
OPPORTUNITIES
THREATS
Significant export potential to the
R & D efforts of Indian
developing as well as developed
pharmaceutical
companies
countries
hampered
by
lack
of
enabling
regulatory
requirement.
Licensing deals and collaborations
For instance, restrictions on
with MNCs for New Chemical
animal
Entities
testing, outdated patent office, etc
and New Drug Delivery Systems
Product patent regime poses
Contract manufacturing
serious challenges to domestic
arrangements with MNCs
industries unless it invests in R &
Potential for developing the
D.
company as a center for
Drug (Pricing Control) Order puts
International Clinical Trials
unrealistic ceilings on product
Drugs
that
address
rising
prices and profitability. and
prevents
pharmaceutical
multifactorial disorders such as
companies
from
generating
cancer as well as lifestyle disorders
investible surplus.
Exports effort hampered by
such as obesity are also likely to
procedural hurdles in India as well
experience strong revenue growth
as
non-tariff
barriers
imposed
abroad.
H.K.E. SOCIETYS
30
30
H.K.E. SOCIETYS
31
31
H.K.E. SOCIETYS
32
32
AWARDS /ACHIEVEMENTS
H.K.E. SOCIETYS
33
33
FINANCIAL STATEMENT
TABLE 6
Profit and Loss Account for the Year Ended 31st March 2014
(Rs. In Millions)
Particulars
YRC
Less: Sales Returns
Less: Excise
Net Sales
EXPENDITURE :
Increase/Decrease in
Stock
Raw Materials Consumed
Power & Fuel Cost
Employee Cost
Other Manufacturing
Expenses
General and
Administration Expenses
Selling and Distribution
Expenses
Miscellaneous Expenses
Expenses Capitalised
Total Expenditure
PBIDT (Excl OI)
Other Income
Operating Profit
Interest
PBDT
Depreciation
Profit Before Taxation &
Exceptional Items
Exceptional Income /
Expenses
Profit Before Tax
Provision for Tax
PAT
Extraordinary Items
Adj to Profit After Tax
Profit Balance B/F
Appropriations
Equity Dividend (%)
Earnings Per Share (Rs.)
Book Value (Rs.)
H.K.E. SOCIETYS
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
0
69.94
5273.68
0
70.85
3281.96
0
52.68
2797.59
0
58.24
2575.44
0
54.35
2344.60
-118.28
3168.60
155.48
374.36
37.08
2012.93
88.32
227.61
-170.12
1915.66
76.35
169.41
88.40
1450.31
56.50
128.47
-146.67
1427.59
45.19
101.30
228.00
132.84
101.97
78.35
46.13
110.99
76.75
64.50
40.19
30.37
72.23
95.62
0
4086.99
1186.69
88.53
1275.22
43.48
1231.74
210.92
41.12
11.23
0
2627.89
654.07
50.06
704.14
19.45
684.69
127.54
30.25
46.69
0
2234.71
562.88
77.86
640.74
19.71
621.03
114.38
28.42
10.90
0
1881.53
693.91
90.97
784.88
22.73
762.14
104.21
55.61
13.44
0
1572.96
771.64
53.32
824.96
54.87
770.09
97.65
1020.82
557.15
506.65
657.93
672.44
0
1020.82
212.25
808.57
0
0
1821.52
2630.09
50.00
21.98
112.15
-1.04
556.11
96.52
459.60
0
0
1451.48
1911.07
65.00
18.74
134.88
6.27
512.92
115.45
397.48
0
0
1132.15
1529.63
45.00
16.21
117.15
0
657.93
149.11
508.82
0
0
714.79
1223.61
40.00
21.18
96.09
0
672.44
212.31
460.13
0
1.07
321.63
782.83
35.00
20.89
50.94
34
34
TABLE 7
Blanace Sheet for the Year Ended 31st March 2014
(Rs. In Millions)
Particulars
Share Capital
Share Warrants &
Outstandings
Total Reserves
Shareholder's Funds
Minority Interest
Long-Term Borrowings
Secured Loans
Unsecured Loans
Deferred Tax Assets /
Liabilities
Other Long Term
Liabilities
Long Term Trade
Payables
Long Term Provisions
Total Non-Current
Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Mar 2014
73.57
Mar 2013
49.05
Mar 2012
49.05
Mar 2011
48.05
Mar 2010
44.05
0.00
4052.08
4125.65
0
0
373.80
0
0.00
3258.81
3307.86
0
0
432.19
0
0.00
2823.95
2872.99
0
0
50.75
0
43.75
2260.31
2352.11
0
0
111.63
0
0.00
1077.90
1121.95
0
0
671.74
15.30
269.75
206.30
191.08
152.62
136.41
0
8.79
0
3.12
0
7.58
0
6.00
0
0
652.34
0
866.12
356.29
220.22
47.79
1490.42
6268.40
641.61
0
477.38
215.07
389.23
38.00
1119.69
5069.16
249.41
0
531.35
182.77
357.32
26.00
1097.43
4219.83
270.24
0
239.96
142.70
278.59
22.41
683.66
3306.01
823.46
0
375.66
8.15
0
92.77
476.58
2421.98
Continued..
H.K.E. SOCIETYS
35
35
Particulars
ASSETS
Non-Current Assets
Gross Block
Less: Accumulated
Depreciation
Less: Impairment of
Assets
Net Block
Lease Adjustment A/c
Capital Work in Progress
Intangible assets under
development
Pre-operative Expenses
pending
Assets in transit
Non-Current Investments
Long Term Loans &
Advances
Other Non-Current Assets
Total Non-Current
Assets
Current Assets Loans &
Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and
Advances
Total Current Assets
Net Current Assets
(Including Current
Investments)
Total Current Assets
Excluding Current
Investments
Miscellaneous Expenses
not written off
Total Assets
Contingent Liabilities
Total Debt
Book Value
Adjusted Book Value
H.K.E. SOCIETYS
Mar 2014
0
0
3387.32
Mar 2013
0
0
2126.99
Mar 2012
0
0
1881.79
Mar 2011
0
0
1629.96
Mar 2010
0
0
1559.63
810.71
601.44
473.38
359.01
280.24
0
2576.61
0
492.35
0
1525.56
0
1141.79
0
1408.41
0
552.66
0
1270.95
0
12.55
0
1279.39
0
30.58
0.93
0
0
650.65
0
0
370.07
0
0
331.13
0
0
280.84
0
0
36.95
300.60
4.64
199.92
3.99
171.76
3.44
24.56
3.00
0
0
4024.84
3242.25
2467.40
1591.90
1346.92
0
101.39
1089.50
603.09
8.05
173.84
0
502.82
661.30
318.77
105.26
112.13
0
680.22
598.70
331.87
19.49
65.06
0
0
374.44
336.34
837.48
60.75
0
0
436.46
314.86
17.98
48.51
267.69
2243.56
126.65
1826.91
57.10
1752.43
105.10
1714.10
257.25
1075.06
753.15
707.22
655.00
1030.45
598.49
2142.17
1324.09
1072.21
1714.10
1075.06
0
6268.40
0
5069.16
0
4219.83
0
3306.01
0
2421.98
400.69
981.66
134.88
89.92
559.08
548.64
117.15
78.10
266.72
501.84
96.09
64.06
217.35
687.05
50.94
33.96
430.02
800.78
112.15
112.15
36
36
TABLE 8
RATIO ANALYSIS
Particulars
Operational &
Financial Ratios
Mar 2014
21.98
18.74
16.21
21.18
20.89
CEPS( )
27.71
15.96
13.91
17.01
16.88
DPS( )
1.00
1.30
0.90
0.80
0.70
Book NAV/Share( )
Tax Rate (%)
112.15
20.79
134.88
17.36
117.15
22.51
96.09
22.66
50.94
31.57
Particulars
Margin Ratios
Core EBITDA Margin
(%)
EBIT Margin (%)
Pre Tax Margin (%)
PAT Margin (%)
Cash Profit Margin
(%)
22.21
19.92
19.10
15.13
19.51
17.17
16.59
13.71
19.75
18.69
18.00
13.95
26.35
25.84
24.98
19.32
32.17
30.32
28.03
19.18
19.08
17.51
17.96
23.28
23.25
Particulars
Performance Ratios
ROA (%)
ROE (%)
ROCE (%)
Asset Turnover(x)
Sales/Fixed Asset(x)
Working
Capital/Sales(x)
14.26
21.75
23.10
0.94
1.94
9.90
14.87
14.93
0.72
1.67
10.56
15.34
16.97
0.76
1.62
17.77
29.67
29.19
0.92
1.65
20.77
51.11
42.03
1.08
1.61
7.10
4.74
4.35
2.56
4.01
Particulars
Efficiency Ratios
Fixed Capital/Sales(x)
Receivable days
Inventory Days
Payable days
Mar 2014 Mar 2013 Mar 2012 Mar 2011 Mar 2010
H.K.E. SOCIETYS
0.52
31.48
59.79
59.11
0.60
35.42
68.58
68.15
0.62
42.78
62.31
62.12
0.61
45.13
56.19
57.27
0.62
38.28
50.66
61.52
37
37
Particulars
Valuation Parameters
PER(x)
PCE(x)
Price/Book(x)
Yield (%)
EV/Net Sales(x)
EV/Core EBITDA(x)
EV/EBIT(x)
EV/CE(x)
M Cap / Sales
Mar 2012
18.78
14.89
3.68
0.24
3.03
12.53
15.01
2.55
2.88
14.78
11.48
2.05
0.38
2.29
10.00
12.03
1.52
2.10
12.41
10.30
2.73
0.30
2.32
7.61
8.78
1.81
2.45
Particulars
Growth Ratio
Net Sales Growth (%)
Core EBITDA
Growth (%)
EBIT Growth (%)
PAT Growth (%)
EPS Growth (%)
60.69
17.31
8.63
9.85
72.45
81.10
84.91
75.93
17.29
9.89
8.06
15.63
15.63
-18.36
-21.75
-21.88
-23.48
-4.86
-6.41
10.58
1.38
200.89
240.28
520.37
520.36
Particulars
Financial Stability
Ratios
Total Debt/Equity(x)
Current Ratio(x)
Quick Ratio(x)
Interest Cover(x)
Total Debt/M cap(x)
0.19
1.51
0.81
24.48
0.05
0.22
2.51
1.98
29.94
0.08
8.74
10.26
1.82
0.53
2.10
9.80
11.99
1.36
1.84
0.30
1.63
1.05
29.59
0.24
0.19
1.60
1.06
27.03
0.09
8.49
10.51
5.22
0.26
2.78
7.92
8.98
2.70
2.50
0.61
2.26
1.34
13.25
0.18
H.K.E. SOCIETYS
38
38
H.K.E. SOCIETYS
39
39
40
40
H.K.E. SOCIETYS
41
41
Cash Management
Receivables Management
Inventory Management
A. CASH MANAGEMENT
Cash is the important current asset for the operation of the business. Cash is the
basic input needed to keep the business running on a continuous basis; it is also the ultimate
output expected to be realized by selling the service or product manufactured by the firm.
The firm should keep sufficient cash, neither more nor less.
Cash is the liquid form of an asset. It is the ready money available in the firm or
with the business, essential for its operations. A firm needs the cash for the following three
purposes:
a. The Transaction Motive:
The firm should keep cash to conduct its business in the ordinary course. The firm
needs cash primarily to make payment for purchases, sales, wages and salaries etc.
b. The Precautionary Motive:
The firm should keep cash to meet contingencies in future. It provides a cushion or
buffer to withstand some unexpected emergency.
c. The Speculative Motive:
To tap profits from opportunities arising from fluctuations in commodity prices,
security prices, interest rates etc. the company with surplus cash is in a better
position to exploit such situations.
B. RECEIVABLES MANAGEMENT
Receivable represents amounts owed to the firm as a result of sale of goods or
services on the ordinary course of business. These are claims of the firm against its
customers and form part of its current assets. These receivables are carried for the
customers. The period of credit and extent of receivables depends upon the credit policy
followed by the firm. The main purpose of maintaining or investing in receivables is to
meet competitors, to increase sales, and to maintain a cordial relationship with the clients.
Receivables management is the process of making decisions relating to investment
in trade debtors. However, at the same time, investment in this current asset involves cost
considerations also. Therefore there is always a risk of bad debts too.
H.K.E. SOCIETYS
42
42
C. INVENTORY MANAGEMENT
Background of the study of Inventory Management
Every enterprise needs inventory for smooth running of its activities. It serves as a
link between the production and the distribution processes. There is generally a time lag,
between the recognition of a need and its fulfillment. The greater the time lag, the higher
the requirements of inventory. It also provides a cushion for future price fluctuation.
The investment in inventories constitutes the most significant part of current
assets/working capital in most of the undertakings. Thus it is very essential to have a proper
control and management of inventories. The purpose of inventory is to ensure availability
of materials in sufficient quantity as and when required and also to minimize investment in
inventories.
Inventories represent the second largest asset category for manufacturing
companies. The proportion of inventories to total assets generally varies between 15 and
30%.Decisions relating to inventories are taken primarily by executives in production,
purchasing and marketing departments. Hence the importance of inventory management
cannot be overemphasized.
What are inventories?
Every one, be it a firm, or an establishment or an individual, is familiar with the
word stock because each of these carry some items to meet their requirements. In trade and
industry, the word stock, is called inventories.
Economy in purchasing
Administrative simplicity
Raw materials
Work-in-progress
Finished goods
Tools
Supplies
Machinery spares
H.K.E. SOCIETYS
43
43
1. Raw materials:
Raw materials form a major input into the organization. They are required to carry
out production activities uninterruptedly. The quantity of raw materials required will be
determined by the rate of consumption and the time required for replenishing the supplies.
The factors like availability of raw materials and Government regulations etc., too affect
the stock of raw materials.
2. Work-in-progress:
The work-in-progress is the stage of stocks, which are in raw materials and finished
goods. The raw materials enter the process of manufacturing but they are yet to attain a
final shape of finished goods. The quantum of work-in-progress depends upon the time
taken in the manufacturing: the more will be the amount of work-in-progress.
3. Finished goods:
These are the goods which are ready for the consumers. The stock of finished goods
provides a buffer between production and market. The purpose of maintaining inventory is
to ensure proper supply of goods to customers. In some concerns the production is
undertaken on order basis, in these concerns there will be need for finished goods. The need
for finished goods inventory will be more when production is undertaken in general without
waiting for specific orders.
4. Consumables:
These are materials which are needed to smoothen the process of production These
materials do not directly enter production but they act as catalysts etc,. Consumables may
be classified according to their consumption and criticality, Generally, consumable stores
do not create any supply problem and form a small part of production. There can be
instances where these materials may account for much value than the raw materials. The
fuel oil may form a substantial part of cost.
5. Spares:
The consumption pattern of raw materials, consumables, finished goods are
different from that of spares. The stocking policy of spares is different from industry to
industry. Some industries like transport will require more spares than order concerns. The
costly spare parts like engines: maintenance parts, etc,. are not discarded after use but rather
they are kept in ready position for future use. All decisions about spares are based on
financial cost of inventory on such spares and the cost that may arise due to their nonavailability.
H.K.E. SOCIETYS
44
44
To stabilize production
20 century that the analytical techniques were developed to study them. The initial impetus
for analysis expectedly cones from manufacturing sector. It was until after World War II that a
concerted effort an risk and uncertainly aspects of inventory has made. In theory, inventory is
an area of organized operation that is well developed.
Material is a very important factor of production. It includes physical commodities used
to manufacture the final end product. It is the starting point from which the first operation starts.
It is inventories and does not get waste and exhaust (unless it is deteriorated) with the passage
of time as labor is wasted that it can be purchased on varying quantities according to the
requirements of firm where as often Clements of cost like labor and other services cannot be
easily varied once they are established. Materials account for nearly 60% of cost of production
as it is clear from an analysis of the financial statements of larger number of private and public
sector organization.
According to the Indian Association of material marketing 64 paisa in a rupee is spent
in materials by Indian Industries, 16 paisa on labor and the rest of one rupee on spent on
overheads, thus the importance of material control lies in the fact that any savings made in the
cost of materials will go a long way in reducing cost of the production and improving the
profitability of a concern.
Studies by experts in this field have highlighted the fact that if an organization can
affect 5% saving in material cost, it would be as good as the increasing the production or sales
by about 36%.
Proper control of materials is necessary from the time orders for purchase of materials
is placed with suppliers until they have been consumed. The object of material may be reduced
in other words, efforts are to be made to reduce the cost material when it is purchased, stored
and used.
H.K.E. SOCIETYS
45
45
ii.
iii.
iv.
v.
turnover ratio or an Activity ratio is a measure of movement and indicates as to how frequently
an account has moved/turned over during a period it shows as to how efficiently and effectively
the assets of the firm are being utilized. The activities ratios measure the effectiveness with
which the firm uses its resources. These ratios are usually calculated with reference to sales/cost
of goods sold and are expressed in terms of rates or times.
H.K.E. SOCIETYS
46
46
Liquidity ratios
Liquidity ratio may be defined as financial ratio which throws light on short term
solvency of the firm. It measures the ability of the firm to meet its current obligations i.e.
working capital requirements.
A firm should ensure that it doesnt suffer from lack of liquidity and also see that
it doesnt have excess liquidity. Failure of a company is to not meet its obligations due to
lack of sufficient liquidity will result in a poor credit worthiness and loss of creditors
confidence. Therefore it is necessary to maintain a proper balance between high liquidity
and lack of liquidity. So liquidity ratio measures the ability of a firm to meet its short terms
obligations and reflects short-term financial strength of the firm.
Credit analysts, those interpreting the financial ratios from the prospects of a lender,
focus on the downside risk since they gain none of the upside from an
improvement in operations. They pay great attention to liquidity and leverage ratios to
ascertain a companys financial risk.
Liquidity ratio needs establishing a relationship between cash and other current
assets to current obligations to provide quick measures of liquidity. These ratios are also
termed as working capital ratio or short-term solvency ratio. An enterprise must have
adequate working capital to run its day-to-day operations.
Inadequacy of working capital may bring the entire business operation to a grinding halt
because of inability of the enterprise to pay for wages, materials and other regular expenses.
The liquidity refers to the maintenance of cash, bank balance and those assets which
are easily convertible into cash in order to meet the liabilities as and when arising. the
liquidity ratios study the firms short term solvency and its ability to payoff the liabilities.
It should be intuitive to observe that a firm, no matter how profitable it is, cannot continue
to exist unless it is able to meet its obligations as they arise. The day-to-day problems of
financial management consist of highly important task of finding sufficient cash to meet
current obligations. The short term liquidity risk, arises primarily from the need to finance
current operations. To the extent that the firm has to make payments to its suppliers before
it is paid for the goods and services it provides, a cash short fall has to be met usually
through the short term borrowings. Although this financing of working capital needs is
routinely done in most firms, the liquidity ratios have been devised to keep a track on the
extent of the firms exposure to the risk that it will not be able to meet its short term
obligations. Liquidity ratios as a group are intended to provide information about a firms
liquidity and the primary concern is the firms ability to pay its current liabilities.
Consequently , these ratios focus on current assets and current liabilities.
H.K.E. SOCIETYS
47
47
The liquidity ratios provide a quick measure of liquidity of the firm by establishing a
relationship between its current assets and its current liabilities. If a firm does not have
sufficient liquidity it may not be in a position to meet its credit worthiness. The liquidity ratios
may be called the Balance sheet ratios because the information required for the calculation of
liquidity ratios is available in the balance sheet only. Some of the common liquidity ratios are
which give a picture of a companys short term financial situation or solvency.
I.
Current Ratio
II.
III.
Operating Cycle
The duration of time required to complete the following cycle of events in case
of
H.K.E. SOCIETYS
48
48
CHAPTER 4.
DATA ANALYSIS AND INTERPRETAION
1. Inventory turnover ratio
It signifies the liquidity of the inventory. A high inventory turnover indicates brisk
sales. The ratio is therefore a measure to discover the possible trouble in the form of
over stocking or over valuation.
Inventory turnover
ratio =
Sales
Closing Stock
Or
(If there is no
opening stock)
Avg. Inventory =
Net Sales
2344.60
2575.44
2797.59
3281.96
5273.68
Inventories
325.42
396.48
477.58
616.65
863.87
7.20
6.50
Mar
2010
Mar
2011
5.86
Mar
2012
YEARS
6.10
5.32
Mar
2013
Mar
2014
Interpretation:
The lower the ratio indicates the more efficiency in converting inventory into
accounts receivables through sales. The ratios computed clearly demonstrated that there
is efficiency in inventory management. The ratio can be still increased by following
inventory control techniques like Just in time, buffer stocks etc. These techniques avoid
necessary idle cost of storage on inventory management system.
H.K.E. SOCIETYS
49
49
Table 9.1: Table showing the inventory conversion period (Rs in millions.)
Year
Mar 2010
Mar 2011
Mar 2012
Mar 2013
Mar 2014
Net Sales
2344.60
2575.44
2797.59
3281.96
5273.68
Days
50.66
56.19
62.31
68.58
59.79
80
Graph 1.1
Inventories
325.42
396.48
477.58
616.65
863.87
70
60
DAYS
50
40
30
20
10
0
Mar
2010Mar
2011Mar 2012Mar
YEARS
2013Mar
2014
Interpretation:
If the average collection period extends beyond 60 days, debtors are holding cash that
should have flowed into the department. This means that the department is unable to satisfy
pressing liabilities or to invest that cash.
The inventory conversion period over the years have come down which indicates the
conversion of raw material into finished products is faster in the company. The analysis
shows us the days it was approx. 51 days in 2010 but later increased till 2013 to 68.58 and
again controlled significantly to 59.79 in 2014
H.K.E. SOCIETYS
50
50
Net sales
Debtors
Table 10: Table showing the Debtors turnover ratio (Rs in millons.)
Year
Net Sales
Sundry Debtors
Mar 2010
2344.60
314.86
7.45
Mar 2011
2575.44
336.34
7.66
Mar 2012
2797.59
331.87
8.43
Mar 2013
3281.96
318.77
10.30
Mar 2014
5273.68
603.09
8.74
Graph 2
DEBTOR TURNOVER RATIO
12.00
10.00
7.45
7.66
8.74
8.43
8.00
6.00
4.00
2.00
0.00
Mar
2010
Mar
2011
Mar
2012
YEARS
Mar
2013
Mar
2014
Interpretation:
This ratio shows the extent of trade credit granted and efficiency in the collection
of debts. The debtor ratio does not solve the collection problem, but it acts as an indicator
that an adverse trend is developing.
We see that it was 7.45 in 2010 and it increased to 10.30 in 2013 and again
decreased to 8.74 in 2014
H.K.E. SOCIETYS
51
51
Table 11: Table showing the current asset turnover ratio (Rs in millons.)
Year
Net Sales
Current Assets
Mar 2010
2344.60
2170.93
1.08
Mar 2011
2575.44
2799.39
0.92
Mar 2012
2797.59
3681.04
0.76
Mar 2013
3281.96
4558.28
0.72
Mar 2014
5273.68
5610.30
0.94
Graph 3:
1.2
1.08
0.94
0.92
0.76
0.8
0.72
0.6
0.4
0.2
0
Mar
2010
Mar
2011
Mar
2012
YEARS
Mar
2013
Mar
2014
Interpretation:
The current asset turnover ratio computed clearly implies and indicates there
is more consistency and efficiency in converting current assets into sales throughout 5
years of analysis.
There is gradual decrease from 1.08 in 2010 to 0.92 in 2011
further
there was a slight decrease to 0.76 and 0.72 in 2012 and 2013 but in the coming year
2014 the company strived hard to bring it to0 .94 which clearly indicates efficiency in
its operations.
H.K.E. SOCIETYS
52
52
Table 12: Table showing the Working capital turnover ratio (Rs in millons.)
Year
Mar 2010
Mar 2011
Mar 2012
Mar 2013
Mar 2014
Net Sales
Working Capital
Working Capital turnover
2344.60
584.69
4.01
2575.44
1006.03
2.56
2797.59
643.12
4.35
3281.96
692.40
4.74
5273.68
742.77
7.1
Graph 4:
WORKING CAPITAL RATIO
7.10
4.35
4.01
4.74
2.56
Mar
2010
Mar
2011
Mar
2012
Mar
2013
Mar
2014
YEARS
Interpretation:
The ratio computed clearly indicates that, there is no consistency in the amount of
working capital held and the sales achieved. There is gradual decrease from 4.01 in
2010 to 2.56 in the year 2011 and then there is a sudden gain to 4.35 in the year 2012,
this is because of good financial forecast in respect of probable revenue from sales and
the amount needed for working capital. And it has increased to 7.10 in 2014
H.K.E. SOCIETYS
53
53
=
Table 13: Table showing the days of collection period (Rs in millons.)
Year
Net Sales
Debtors turnover ratio Average collection period
Mar 2010
2344.60
7.45
48.32
Mar 2011
2575.44
7.66
47.00
Mar 2012
2797.59
8.43
42.70
Mar 2013
3281.96
10.30
34.95
Mar 2014
5273.68
8.74
41.19
Graph 5:
PERIOD OF COLLECTION
47.00
50.00
40.00
30.00
20.00
10.00
0.00
42.70
34.95
Mar
2010
Mar
2011
Mar
2012
Mar
2013
41.19
Mar
2014
YEARS
Interpretation:
Average collection period measures the quality of debtors. As shorter
collection period implies prompt payment by debtors. It reduces the chances of bad
debts. A longer collection period implies too liberal and inefficient credit collection
performance. From the above statement we can make out that the company has
inefficient credit collection performance in the year 2013 was good but it become slight
liberal in 2014
54
54
6. Operating cycle
The duration of time required to compl ete the sequence of events.
Operating cycle =
Table 14: Table showing the operating cycle (Rs in millons.)
Year
Mar 2010
Mar 2011
Mar 2012
Mar 2013
Mar 2014
Graph 6:
Net Sales
2344.60
2575.44
2797.59
3281.96
5273.68
Inventories
325.42
396.48
477.58
616.65
863.87
Days
51.11
56.49
62.54
68.77
59.57
DAYS
Operating cycle
70
60
50
40
30
20
10
0
51.11
Mar
2010
56.49
Mar
2011
62.54
68.77
Mar
Mar
2012
2013
YEARS
59.57
Mar
2014
Interpretation:
The duration of production was very high during the year 2014. The company has
taken effective steps in order to reduce the no of days of production but even though in the
year 2010 to 2013 the days of production has increased from 51.11 to 68.77respectively.
But in the latest F.Y 2014 the operating cycle has come down to an significant figure of
59.57 days, which indicates the efficiency achieved in various processes.
H.K.E. SOCIETYS
55
55
7. Current Ratio
This ratio is an indicator of the firms commitment to meet its short-term
liabilities.
=
(Current Assets = Inventories + Sundry Debtors+ Cash and Bank Balances)
(Current Liabilities = Sundry Creditors + Bank overdraft + Deposit received from contractors)
Year
Current Assets Current Liabilities
Current Ratio
Mar 2010
2170.93
960.59
2.26
Mar 2011
2799.39
1115.30
2.51
Mar 2012
3681.04
2300.65
1.60
Mar 2013
4558.28
2796.49
1.63
Mar 2014
5610.30
3715.43
1.51
Graph 7
CURRENT RATIO
Current Ratio
3.00
2.50
2.26
2.51
1.60
2.00
1.63
1.51
1.50
1.00
0.50
0.00
Mar
2010
Mar
2011
Mar
2012
YEARS
Mar
2013
Mar
2014
Interpretation:
The current ratio of 2:1 will be considered as ideal under all normal
situations. But the ratios computed indicates lack of funds in current assets, because it
is lower in all the above 5 years compared to normal ratio of 2:1. In the year 2014 it has
fallen to a low of 1.51. There is a constant management of current ratio in the abovementioned 5 years, by which company has overcome the decline in the year 2014.
H.K.E. SOCIETYS
56
56
8. Quick Ratio:
Quick ratio, also called acid-test ratio, establishes a relationship between quick or
liquid assets and current liabilities. An asset is liquid if it can be converted into cash
immediately or reasonably soon without a loss of value. Cash is the most liquid asset. Other
assets that are considered to be relatively liquid and included in quick assets are debtors
and bill receivable and marketable securities (temporary quoted investments). Inventories
are considered to be less liquid. Because they require some time in realising into cash; their
value also has a tendency to fluctuate. Quick ratio can be calculated by dividing uqick assets
by current liabilities.
Inventories
325.42
396.48
477.58
616.65
863.87
Graph 8
Current Liabilities
960.59
1115.30
2300.65
2796.49
3715.43
Quick Ratio
1.92123
2.15451
1.392414
1.409492
1.277491
QUICK RATIO
2.50
1.92
2.15
RATIOS
2.00
1.39
1.41
1.50
1.28
1.00
0.50
0.00
Mar
2010
Mar
2011
Mar
2012
YEARS
Mar
2013
Mar
2014
Interpretation:
The quick ratio is also called as the acid test ratio and is the one of the best measures of
liquidity. The quick ratio is much more conservative measure than the current ratio
The ideal standard of quick ratio should be 1:1 since the organisation has the higher ratio it
is doing extremely well and their ability is very fast to meet the current liabilities.
H.K.E. SOCIETYS
57
57
Chapter 5
Summary of Findings, Conclusion and Suggestions /recommendations
Findings
Total Current asset is maximum in the year 2014 and minimum in the year 2010,
where in current liabilities there is also an increase in the year in 2014 and decrease
in the year 2010. The current asset and current liabilities have reached its maximum
point in the year 2014 in the case of changes in current assets and current liabilities.
Current liabilities constitute a major portion of the total liabilities, which shows that
the firm is dependent more on the short-term borrowings to finance its activities.
The net profit of the organization has seen a rapid growth from 460.13 million
rupees in 2010 to 808.57 million rupees crores in 2014
It is inferred that the cash and bank balance is decreasing from 2010 17.98 million
rupees to 8.05 million rupees in 2014 as the funds are utilized for growth
requirements.
But we see that huge surplus of cash and bank was there in 2011 up to 837.48
million rupees
It is inferred that the inventory is max at 2014 and min at 2011 because of better
techniques in inventory management.
It can be inferred that the companys ability to meet short term liabilities is
improving.
It can be inferred that the liquid asset of the company is maximum during the year
2011 because of increase in fixed deposits and decreased in 2014
H.K.E. SOCIETYS
58
58
If the following suggestions are adopted by Shilpa Medicare Limited, it would definitely
result in the better financial performance and help the company in the long run.
CONCLUSION
Shilpa Medicare Limited has carved a niche for itself in the exceedingly competitive and
quality-conscious sphere of pharmaceuticals manufacturing.
After analyzing the data and coming through the data and graphs of various years the
company has earned a good profit from the initial years itself. The working capital, cash,
liquidity position of the company is very good.
It is necessary to say that, the study, helped to gain a good exposure on organization and its
operational areas at Shilpa Medicare Limited.
H.K.E. SOCIETYS
59
59
BIBLIOGRAPHY
BOOKS:
I.
II.
III.
IV.
Webliography:
http://www.vbshilpa.com/
http://www.moneycontrol.com
http://economictimes.indiatimes.com
http://www.pharmatutor.org
Other sources:
1. Annual reports of Shilpa Medicare Ltd. for the year 2013-14
H.K.E. SOCIETYS
60
60
ANNEXURE
H.K.E. SOCIETYS
61
61
H.K.E. SOCIETYS
62
62
H.K.E. SOCIETYS
63
63